Search research articles
Contact Us
Filters
Showing results (141-150 of 166) with videos related to
Page
of 17
Sort By:
Cancer Research
|
June 19, 2001
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2
M Cuello, S A Ettenberg, A S Clark, et al.
Journal of Medicinal Chemistry
|
February 20, 2004
Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents
Gary H Posner, Andrew J McRiner, Ik-Hyeon Paik, et al.
The Journal of Organic Chemistry
|
May 16, 1997
Antiproliferative Hybrid Analogs of the Hormone 1alpha,25-Dihydroxyvitamin D(3): Design, Synthesis, and Preliminary Biological Evaluation
Gary H. Posner, Jae Kyoo Lee, M. Christina White, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
January 16, 2007
Difluoromethyl analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: Design, synthesis, and preliminary biological evaluation
Gary H Posner, Byung Chul Suh, Kimberly S Petersen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 19, 1999
Biological effects of 1alpha-hydroxy- and 1beta-(hydroxymethyl)-vitamin D compounds relevant for potential colorectal cancer therapy
H Hofer, G m Ho, M Peterlik, et al.
Journal of Medicinal Chemistry
|
September 10, 1999
Conceptually new sulfone analogues of the hormone 1alpha, 25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation
G H Posner, Q Wang, G Han, et al.
Journal of Cellular Biochemistry
|
October 4, 2005
Anticancer effects of the novel 1alpha, 25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastoma
C Damodar Reddy, Ratnakar Patti, Asha Guttapalli, et al.
Bioorganic & Medicinal Chemistry
|
September 13, 2001
A non-calcemic sulfone version of the vitamin D(3) analogue seocalcitol (EB 1089): chemical synthesis, biological evaluation and potency enhancement of the anticancer drug adriamycin
G H Posner, K R Crawford, S Peleg, et al.
Journal of Medicinal Chemistry
|
December 24, 2004
Potent, selective and low-calcemic inhibitors of CYP24 hydroxylase: 24-sulfoximine analogues of the hormone 1alpha,25-dihydroxyvitamin D(3)
Mehmet Kahraman, Sandra Sinishtaj, Patrick M Dolan, et al.
Steroids
|
December 8, 2004
Low-calcemic, efficacious, 1alpha,25-dihydroxyvitamin D3 analog QW-1624F2-2: calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry
Gary H Posner, Heung Bae Jeon, Amy Sarjeant, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 166) with videos related to
Sort By:
Page
of 17
Cancer Research
|
June 19, 2001
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2
M Cuello, S A Ettenberg, A S Clark, et al.
Journal of Medicinal Chemistry
|
February 20, 2004
Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents
Gary H Posner, Andrew J McRiner, Ik-Hyeon Paik, et al.
The Journal of Organic Chemistry
|
May 16, 1997
Antiproliferative Hybrid Analogs of the Hormone 1alpha,25-Dihydroxyvitamin D(3): Design, Synthesis, and Preliminary Biological Evaluation
Gary H. Posner, Jae Kyoo Lee, M. Christina White, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
January 16, 2007
Difluoromethyl analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: Design, synthesis, and preliminary biological evaluation
Gary H Posner, Byung Chul Suh, Kimberly S Petersen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 19, 1999
Biological effects of 1alpha-hydroxy- and 1beta-(hydroxymethyl)-vitamin D compounds relevant for potential colorectal cancer therapy
H Hofer, G m Ho, M Peterlik, et al.
Journal of Medicinal Chemistry
|
September 10, 1999
Conceptually new sulfone analogues of the hormone 1alpha, 25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation
G H Posner, Q Wang, G Han, et al.
Journal of Cellular Biochemistry
|
October 4, 2005
Anticancer effects of the novel 1alpha, 25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastoma
C Damodar Reddy, Ratnakar Patti, Asha Guttapalli, et al.
Bioorganic & Medicinal Chemistry
|
September 13, 2001
A non-calcemic sulfone version of the vitamin D(3) analogue seocalcitol (EB 1089): chemical synthesis, biological evaluation and potency enhancement of the anticancer drug adriamycin
G H Posner, K R Crawford, S Peleg, et al.
Journal of Medicinal Chemistry
|
December 24, 2004
Potent, selective and low-calcemic inhibitors of CYP24 hydroxylase: 24-sulfoximine analogues of the hormone 1alpha,25-dihydroxyvitamin D(3)
Mehmet Kahraman, Sandra Sinishtaj, Patrick M Dolan, et al.
Steroids
|
December 8, 2004
Low-calcemic, efficacious, 1alpha,25-dihydroxyvitamin D3 analog QW-1624F2-2: calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry
Gary H Posner, Heung Bae Jeon, Amy Sarjeant, et al.
Page
of 17